Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.
To explore emerging technologies and treatment strategies for effective glaucoma management.
Approach:
Key Findings:
10-2 visual field testing can identify central defects missed by traditional testing.
SLT can lead to long-term medication-free periods and lower progression rates.
Normal-tension glaucoma may progress despite controlled IOP; systemic factors should be evaluated.
Nocturnal IOP fluctuations can impact disease progression.
Emerging drug-delivery technologies may enhance medication adherence.
MIGS can improve patient quality of life and reduce medication side effects.
Interpretation:
Successful glaucoma management requires a comprehensive approach that includes IOP reduction, structural and functional testing, and consideration of patient-specific factors.
Conclusion:
A multifaceted strategy is essential for effective glaucoma management, integrating new technologies and individualized patient care.
In the 2026 AGS Lecture, Louis R. Pasquale, MD, FARVO, discussed how genetics, metabolism, and understanding the impact of myopia on the lamina support system may redefine optic nerve protection.